Patents by Inventor Ingo Markus KLAGGE

Ingo Markus KLAGGE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC LOW DENSITY LIPOPROTEIN - RELATED PROTEIN 6 (LRP6) MULTIVALENT ANTIBODIES
    Publication number: 20200377603
    Abstract: The present invention relates to antibodies targeting LRP6 and compositions and methods of use thereof.
    Type: Application
    Filed: February 24, 2020
    Publication date: December 3, 2020
    Inventors: Feng Cong, Seth Ettenberg, Felix Hartlepp, Ingo Markus Klagge
  • Compositions and Methods of Use for Therapeutic Low Density Lipoprotein-related protein 6 (LRP6) Antibodies
    Publication number: 20170362326
    Abstract: The present invention relates to antibodies targeting LRP6 and compositions and methods of use thereof.
    Type: Application
    Filed: March 17, 2016
    Publication date: December 21, 2017
    Applicant: NOVARTIS AG
    Inventors: Feng CONG, Seth ETTENBERG, Felix HARTLEPP, Ingo Markus KLAGGE
  • LINGO Binding Molecules and Pharmaceutical Use Thereof
    Publication number: 20140255415
    Abstract: The present invention provides a binding molecule which is capable of binding to the rat, cynomolgus monkey and human LINGO polypeptide, a polynucleotide encoding such binding molecule; an expression vector comprising said polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell which comprises an expression system as defined above; the use of such binding molecule as a pharmaceutical, especially in the treatment to promote axonal regeneration/plasticity; a pharmaceutical composition comprising said binding molecule; and a method of treatment of diseases associated with axonal degeneration and demyelination.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: NOVARTIS AG
    Inventors: Marta CORTES-CROS, Ingo Markus KLAGGE, Josef PRASSLER, Adrian Robert WALMSLEY, William Leonard WISHART
  • LINGO Binding Molecules and Pharmaceutical Use Thereof
    Publication number: 20140037639
    Abstract: The present invention provides a binding molecule which is capable of binding to the rat, cynomolgus monkey and human LINGO polypeptide, a polynucleotide encoding such binding molecule; an expression vector comprising said polynucleotide; an expression system comprising a polynucleotide capable of producing a binding molecule; an isolated host cell which comprises an expression system as defined above; the use of such binding molecule as a pharmaceutical, especially in the treatment to promote axonal regeneration/plasticity; a pharmaceutical composition comprising said binding molecule; and a method of treatment of diseases associated with axonal degeneration and demyelination.
    Type: Application
    Filed: September 26, 2013
    Publication date: February 6, 2014
    Applicant: NOVARTIS AG
    Inventors: Marta CORTES-CROS, Ingo Markus KLAGGE, Josef PRASSLER, Adrian Robert WALMSLEY, William Leonard WISHART